Stockreport

U.S. Food and Drug Administration Lifts Partial Clinical Hold on Opdivo (nivolumab)-based Combination Study in Multiple Myeloma

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF FDA action removes partial hold on CheckMate -602, the last of holds previously placed on three Opdivo-based combination trials in relapsed or refractory [Read more]